Loading...

INMB - INmune Bio, Inc.

Top Biomed Signal for 06-25-2022
Top Biomed Stock Signal: INMB


Loading Chart INMB

Stock Signal Information


Signal

Top Biomed Stock Signal: INMB
Report Date: 06-25-2022
Symbol: INMB - INmune Bio, Inc.
Sector:
Industry:
Top Biomed Stock Signal: INMB

  INMB Technical Analysis

Company Contact

INmune Bio, Inc. (INMB)
1200 Prospect St Ste 525
La Jolla, CALIFORNIA 33432
Phone: 18589643720
Website: https://www.inmunebio.com
CEO: Dr. Raymond Joseph Tesi

INMB, INmune Bio, Inc.

INMB INmune Bio, Inc. Logo Image

NASDAQ, NASDAQ Capital Market


Company Profile

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.